Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Strohalm

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Folia Microbiologica|January 1, 1997
Morphology of rat kidney and thymus after native and antibody-coupled cyclosporin A application (reduced toxicity of targeted drug)P Rossmann, B Ríhová, J Strohalm, et al.
Journal of Drug Targeting|May 9, 2002
In vitro and in vivo effect of HPMA copolymer-bound doxorubicin targeted to transferrin receptor of B-cell lymphoma 38C13M Kovár, J Strohalm, K Ulbrich, et al.
Bioscience Reports|October 1, 1986
Pinocytic capture and exocytosis of rat immunoglobulin IgG-N-(2-hydroxypropyl)methacrylamide copolymer conjugates by rat visceral yolk sacs cultured in vitroR Duncan, H C Cable, J Strohalm, et al.
Journal of Biomedical Materials Research|November 1, 1987
Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to ratsL W Seymour, R Duncan, J Strohalm, et al.
Journal of Drug Targeting|October 8, 2011
Novel star HPMA-based polymer conjugates for passive targeting to solid tumorsT Etrych, J Strohalm, P Chytil, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
A possibility to overcome P-glycoprotein (PGP)-mediated multidrug resistance by antibody-targeted drugs conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer carrierM St'astný, J Strohalm, D Plocová, et al.
Transplantation|June 27, 1997
Abnormal differentiation of thymocytes induced by free cyclosporine is avoided when cyclosporine bound to N-(2-hydroxypropyl)methacrylamide copolymer carrier is usedM St'astný, K Ulbrich, J Strohalm, et al.
Journal of Drug Targeting|January 1, 1996
Gamma scintigraphy of the biodistribution of 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in mice with transplanted melanoma and mammary carcinomaM V Pimm, A C Perkins, J Strohalm, et al.
Clinical Immunology and Immunopathology|January 1, 1988
Antibody-directed affinity therapy applied to the immune system: in vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibodyB Ríhová, P Kopecková, J Strohalm, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 21, 2000
Polymeric drugs based on conjugates of synthetic and natural macromolecules. I. Synthesis and physico-chemical characterisationK Ulbrich, V Subr, J Strohalm, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Folia Microbiologica|January 1, 1997
Morphology of rat kidney and thymus after native and antibody-coupled cyclosporin A application (reduced toxicity of targeted drug)P Rossmann, B Ríhová, J Strohalm, et al.
Journal of Drug Targeting|May 9, 2002
In vitro and in vivo effect of HPMA copolymer-bound doxorubicin targeted to transferrin receptor of B-cell lymphoma 38C13M Kovár, J Strohalm, K Ulbrich, et al.
Bioscience Reports|October 1, 1986
Pinocytic capture and exocytosis of rat immunoglobulin IgG-N-(2-hydroxypropyl)methacrylamide copolymer conjugates by rat visceral yolk sacs cultured in vitroR Duncan, H C Cable, J Strohalm, et al.
Journal of Biomedical Materials Research|November 1, 1987
Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to ratsL W Seymour, R Duncan, J Strohalm, et al.
Journal of Drug Targeting|October 8, 2011
Novel star HPMA-based polymer conjugates for passive targeting to solid tumorsT Etrych, J Strohalm, P Chytil, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
A possibility to overcome P-glycoprotein (PGP)-mediated multidrug resistance by antibody-targeted drugs conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer carrierM St'astný, J Strohalm, D Plocová, et al.
Transplantation|June 27, 1997
Abnormal differentiation of thymocytes induced by free cyclosporine is avoided when cyclosporine bound to N-(2-hydroxypropyl)methacrylamide copolymer carrier is usedM St'astný, K Ulbrich, J Strohalm, et al.
Journal of Drug Targeting|January 1, 1996
Gamma scintigraphy of the biodistribution of 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugates in mice with transplanted melanoma and mammary carcinomaM V Pimm, A C Perkins, J Strohalm, et al.
Clinical Immunology and Immunopathology|January 1, 1988
Antibody-directed affinity therapy applied to the immune system: in vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibodyB Ríhová, P Kopecková, J Strohalm, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 21, 2000
Polymeric drugs based on conjugates of synthetic and natural macromolecules. I. Synthesis and physico-chemical characterisationK Ulbrich, V Subr, J Strohalm, et al.
Pageof 4